Otitis Media Studies Can Use Four Trial Designs Under FDA Draft Guidance
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA's draft guidance for developing drugs to treat acute bacterial otitis media offers sponsors four possible superiority study designs